Physician profile
John A Ebner
NPI 1295927788
$26,104.20
in general payments reported to CMS, 2019-2025
39 companies · $3,621 in 2025
The $3,621 reported for 2025 was more than what 93% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,071 · 2020: $2,589 · 2021: $4,872 · 2022: $3,840 · 2023: $3,410 · 2024: $3,701 · 2025: $3,621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,633.00 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,559.39 | 2019-2025 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $3,205.86 | 2019-2025 | |
| Amgen INC. | $1,927.64 | 2019-2025 | Otezla, Enbrel, Otezla |
| Leo Pharma INC. | $1,921.27 | 2019-2025 | Adbry, Anzupgo |
| Sun Pharmaceutical Industries INC. | $1,811.68 | 2019-2025 | Blu-U, Odomzo, Ilumya |
| Janssen Biotech, INC. | $1,753.33 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Ucb, INC. | $1,276.10 | 2019-2025 | Bimzelx, Cimzia |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $1,239.76 | 2019-2024 | Siliq, Targretin, Duobrii |
| Lilly USA, LLC | $874.85 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Genentech USA, INC. | $763.81 | 2019-2023 | Xolair |
| Genzyme Corporation | $758.28 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $719.96 | 2019-2025 | Dupixent, Libtayo |
| Pfizer INC. | $655.18 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $562.97 | 2022-2025 | Sotyktu |
| Regeneron Pharmaceuticals, INC. | $526.08 | 2019 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ebner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.